
Journal of Medicinal Chemistry p. 425 - 432 (1993)
Update date:2022-09-26
Topics:
Burke Jr.
Lim
Marquez
Li
Bolen
Stefanova
Horak
A study was undertaken to prepare inhibitors of the lymphocyte protein- tyrosine kinase p56(lck). Using the known p56(lck) inhibitor 3,4-dihydroxy- α-cyanocinnamamide (4) as a lead compound, bicyclic analogues were designed as conformationally constrained
View MoreTaizhou KEDE Chemical.Co.,Ltd.
Contact:86-576-84613060
Address:Jiangkou Chemical Zoon
Tianjin SPHINX SCIENTIFIC LAB.
Contact:+86-022-66211289
Address:Tianda high-tech Park. No.80,the 4th Avenue
Contact:+86-15850770348
Address:51 OF XIANGFANGCUN ROAD, Nanjing 210002, China
Contact:86-512-69362780,69362785
Address:No.69 Weixin Road,Weiting Town,Suzhou Industrial Park
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Doi:10.1021/ol202751s
(2011)Doi:10.1007/s00044-011-9857-0
(2012)Doi:10.1021/jm00080a028
(1992)Doi:10.1055/s-1991-26464
(1991)Doi:10.1021/jo00016a001
(1991)Doi:10.1021/ja01486a058
(1960)